|
CCDC91 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.436170E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.386640E-01 |
| Normal-vs-Stage2 |
1.734630E-01 |
| Normal-vs-Stage3 |
2.306000E-01 |
| Normal-vs-Stage4 |
1.488760E-01 |
| Stage1-vs-Stage2 |
5.993000E-01 |
| Stage1-vs-Stage3 |
9.441200E-01 |
| Stage1-vs-Stage4 |
3.495400E-01 |
| Stage2-vs-Stage3 |
6.664800E-01 |
| Stage2-vs-Stage4 |
6.432800E-01 |
| Stage3-vs-Stage4 |
3.661600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.002970E-01 |
| Normal-vs-AfricanAmerican |
6.087400E-01 |
| Normal-vs-Asian |
3.472000E-01 |
| Caucasian-vs-AfricanAmerican |
3.647400E-01 |
| Caucasian-vs-Asian |
3.571400E-01 |
| AfricanAmerican-vs-Asian |
2.511000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.279000E-01 |
| Normal-vs-Female |
3.658600E-01 |
| Male-vs-Female |
6.835200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.380200E-01 |
| Normal-vs-Extreme_Weight |
4.220100E-02 |
| Normal-vs-Obese |
7.084000E-01 |
| Normal-vs-Extreme_Obese |
5.240000E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.430400E-01 |
| Normal_Weight-vs-Obese |
3.985600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.756000E-01 |
| Extreme_Weight-vs-Obese |
1.124250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.724800E-01 |
| Obese-vs-Extreme_Obese |
1.980960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.300600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.124000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.636400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.037800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.790800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.744030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.659770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.135900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.133810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.880200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.174600E-01 |
| Normal-VS-Type2 PRCC |
7.743700E-03 |
| Normal-VS-KIRP CIMP |
3.385400E-01 |
| Normal-VS-Unclassified PRCC |
4.959400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.055700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.987760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.929600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.347800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.743820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.524400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.172470E-02 |
| Normal-vs-N1 |
5.556200E-01 |
| Normal-vs-N2 |
3.929600E-01 |
| N0-vs-N1 |
2.479200E-01 |
| N0-vs-N2 |
7.750400E-01 |
| N1-vs-N2 |
8.049600E-01 |
|
|
